Literature DB >> 20661667

Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer.

Patricia Piña-Sánchez1, Dulce María Hernández-Hernández, Lucia Taja-Chayeb, Ricardo M Cerda-Flores, Ana Lilia González-Herrera, Carlos Rodea-Avila, Teresa Apresa-García, Patricia Ostrosky-Wegman, Guelaguetza Vázquez-Ortíz, Patricia Mendoza-Lorenzo, Alfonso Dueñas-González, Mauricio Salcedo.   

Abstract

Cervical cancer (CC) is the second most common cancer in Mexican women. Human papillomavirus (HPV) infection is necessary but not sufficient for CC development. Furthermore, genetic factors as polymorphisms could be important susceptibility factors. Controversial results regarding TP53 polymorphisms specifically in codon 72 of CC have been reported. In the present work, the exon 4 sequence of TP53 gene in CC and healthy Mexican-mestizo women were analyzed. A group of 111 women with CC and 126 healthy women (control) were included. Peripheral blood cells for polymorphism analysis and cervical scrape for HPV detection were used. PCR of exon 4 of TP53 were subjected to denaturing high-performance liquid chromatography (DHPLC) analysis and sequencing. HPV detection was subjected to PCR and sequencing. The statistical analysis was carried out using the Arlequin software. Codon 72 Arg/Arg was the most common SNP detected, and Hardy-Weinberg analysis showed equilibrium in control and CC samples (P>0.05). Wild type sequence of TP53 exon 4 was detected in 66 and 57% in control and CC samples, respectively. For codon 72 Arg/Arg, differences between control and CC women were found (P=0.043). An association between HPV 16/18 infection and 72 Arg/Arg in woman with CC was found (P=0.026). Haplotype GC (codon 36 and 72) was statistically significantly associated with CC (P=0.011). HPV 16 was the most common viral type. Codon 72 Arg/Arg is the most common polymorphism in the Mexican population and could be associated to HPV 16 and/or HPV 18 infection in CC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661667     DOI: 10.1007/s12032-010-9599-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  32 in total

1.  Single nucleotide polymorphism seeking long term association with complex disease.

Authors:  Brian W Kirk; Matthew Feinsod; Reyna Favis; Richard M Kliman; Francis Barany
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

2.  Two polymorphic variants of wild-type p53 differ biochemically and biologically.

Authors:  M Thomas; A Kalita; S Labrecque; D Pim; L Banks; G Matlashewski
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.

Authors:  M van Duin; P J Snijders; M T Vossen; E Klaassen; F Voorhorst; R H Verheijen; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

4.  Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.

Authors:  A Storey; M Thomas; A Kalita; C Harwood; D Gardiol; F Mantovani; J Breuer; I M Leigh; G Matlashewski; L Banks
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

5.  Human papillomavirus detection by polymerase chain reaction in benign and malignant prostate tissue is dependent on the primer set utilized.

Authors:  M K Terris; D M Peehl
Journal:  Urology       Date:  1997-07       Impact factor: 2.649

6.  Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.

Authors:  S M Schwartz; J R Daling; K A Shera; M M Madeleine; B McKnight; D A Galloway; P L Porter; J K McDougall
Journal:  J Clin Oncol       Date:  2001-04-01       Impact factor: 44.544

7.  [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].

Authors:  Angel Emillo Suárez-Rincón; María Cristina Morán-Moguel; Héctor Montoya-Fuentes; Martha Patricia Gallegos-Arreola; José Sánchez-Corona
Journal:  Ginecol Obstet Mex       Date:  2002-07

8.  p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Authors:  Daniele Bergamaschi; Milena Gasco; Louise Hiller; Alexandra Sullivan; Nelofer Syed; Giuseppe Trigiante; Isik Yulug; Marco Merlano; Gianmauro Numico; Alberto Comino; Marlene Attard; Olivier Reelfs; Barry Gusterson; Alexandra K Bell; Victoria Heath; Mahvash Tavassoli; Paul J Farrell; Paul Smith; Xin Lu; Tim Crook
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

9.  Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations.

Authors:  Hugo Sousa; Alexandra M Santos; Daniela Pinto; Rui Medeiros
Journal:  Int J Mol Med       Date:  2007-11       Impact factor: 4.101

Review 10.  p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review.

Authors:  Anita Koushik; Robert W Platt; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-01       Impact factor: 4.254

View more
  5 in total

1.  TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer.

Authors:  Ana Coelho; Augusto Nogueira; Sílvia Soares; Joana Assis; Deolinda Pereira; Isabel Bravo; Raquel Catarino; Rui Medeiros
Journal:  Oncol Lett       Date:  2018-03-26       Impact factor: 2.967

2.  Association of TP53 codon 72 and intron 3 16-bp Ins/Del polymorphisms with cervical cancer risk.

Authors:  Tatiana Dantas Rodrigues Laprano; Erika Hardy Lemos; Lia Moreira Pinto Cunha; José Eleutério Júnior; Rosiane Alves de SousaTeles; Silvia Helena Barem Rabenhorst
Journal:  Tumour Biol       Date:  2014-04-30

3.  Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.

Authors:  Ghazi A Alsbeih; Najla M Al-Harbi; Sara S Bin Judia; Hatim A Khoja; Mohamed M Shoukri; Asma M Tulbah
Journal:  Cancer       Date:  2017-04-10       Impact factor: 6.860

Review 4.  The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications.

Authors:  Zheng Hu; Ding Ma
Journal:  Cancer Med       Date:  2018-09-14       Impact factor: 4.452

5.  Polymorphism Located in the Upstream Region of the RPS19 Gene (rs2305809) Is Associated With Cervical Cancer: A Case-control Study.

Authors:  Thaís da Rocha Boeira; Janaina Coser; Jonas Michel Wolf; Bruna Klahr Manggini Cardinal; Ivana Grivicich; Daniel Simon; Vagner Ricardo Lunge
Journal:  J Cancer Prev       Date:  2018-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.